Related Experiment Videos
Abnormal phagocyte chemotaxis: pathophysiology, clinical manifestations, and management of patients
Reviews of Infectious Diseases
|November 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2001
Fibrinogen induces IL-8 synthesis in human neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine or leukotriene B(4).
Journal of immunology (Baltimore, Md. : 1950)·2001
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
The New England journal of medicine·2001
Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation.
Genetics in medicine : official journal of the American College of Medical Genetics·2001
Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.
Reviews of infectious diseases·1991
Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device.
Reviews of infectious diseases·1991
Genetically engineered attenuated herpes simplex viruses.
Reviews of infectious diseases·1991
Did scarlet fever and rheumatic fever exist in Hippocrates' time?
Reviews of infectious diseases·1991
Experimental infection of human subject with Strongyloides species.
Reviews of infectious diseases·1991
Seroepidemiology of pertussis in Italy.
Reviews of infectious diseases·1991
Proteolytic remodeling by Yme1 enables mitochondrial-derived compartment formation.
bioRxiv : the preprint server for biology·2026
Oxidative Stress as a Pathophysiological Core of Obesity: Preclinical Evidence for Antioxidant-Based Therapy Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies.
Pharmaceuticals (Basel, Switzerland)·2026